The Society of Interventional Radiology (SIR) Clinical Specialty Councils are charged with advising and developing programs and services for SIR members on both image-guided procedures and non-procedural patient care. Specific to each Clinical Specialty Council shall provide critical assessment and oversight of the overall status of IR and of existing SIR activities within that clinical domain.
Additionally, the Clinical Specialty Councils are responsible for integrating with SIR and SIR Foundation efforts in clinical practice development, economics and health policy, research, quality, education/training, and communications into an overall development strategy for that clinical domain; and effectively communicate the Clinical Specialty Councils strategic direction to the other SIR divisions on an ongoing basis.
Clinical Specialty Councilors
Neurointerventional Radiology Council
Marty Radvany, MD, FSIR (Councilor)
Venu Vadlamudi, MD, RPVI, FSIR (Vice Chair)
Interventional Oncology Council
Robert Lewandowski, MD, FSIR (Councilor)
Daniel B. Brown, MD, FSIR (Vice Chair)
Renal and GU Council
Gordon McLennan, MD, FSIR (Councilor)
Bart Dolmatch, MD (Vice Chair)
Venous Council
Kush Desai, MD, FSIR (Councilor)
Ronald Winokur, MD, FSIR (Vice Chair)
Pain Management/MSK Council
J. David Prologo, MD, FSIR (Councilor)
Peripheral Arterial Disease (PAD) Council
Robert Lookstein, MD, FSIR (Councilor)
Kumar Madassery, MD (Vice Chair)
Women’s Health Council
Gloria M. Martinez-Salazar, MD, FSIR (Councilor)
Claire Kaufman, MD (Vice Chair)
Pediatric Council
Shellie Josephs, MD, FSIR (Councilor)
Aparna Annam, DO (Vice Chair)
Composition
SIR Clinical Specialty Councils shall consist of a councilor, vice chair, disease state experts assigned to serve as representatives to SIR and SIR Foundation divisions and at-large members from SIR membership. Clinical Specialty Councilors and vice chairs will serve a two-year term. Vice chairs will be appointed by the SIR Nominating Committee for a term of two-years and succeed into the councilor position. Clinical Specialty Council members will serve a term of three years with the eligibility to be reappointed for an additional three-year term.
Clinical Specialty Council representatives will serve on SIR division committees to ensure collaboration and disease state expertise. Clinical Specialty Council division representatives will enhance the work product of the other SIR divisions by serving as their primary resource for up-to-date, disease-specific knowledge, expertise, and perspective. Tasks may range from providing critical guidance to the other divisions upon request to taking primary responsibility for projects and programs. Representatives shall be appointed in collaboration with SIR division councilors. Clinical Specialty Council representatives will serve in dual roles within the councils and the division structure. Representatives terms on the Clinical Specialty Council will correspond with the term within the division structure.
SIR Connect allow members to opt-in to disease state specific discussion groups based on their individual areas of interest.
Save
Save
Save
Save
